The Latest in News from the FDA/CDC

Clinical Psychiatry News

Outpatient care 35% of mental health costs and growing

July 7, 2017

Business of Medicine

Clinical Psychiatry News

Opioid prescribing drops nationally, remains high in some counties

July 7, 2017

Clinical Psychiatry News

Endo removes Opana ER from market

July 6, 2017

Clinical Psychiatry News

Cotempla XR-ODT approved for children, adolescents with ADHD

June 21, 2017

Clinical Psychiatry News

Mydayis approved for teens, adults with ADHD

June 21, 2017

Clinical Psychiatry News

Extended-release Aristada OK’d for 2-month dosing for schizophrenia

June 9, 2017

Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

FDA asks drug maker to shelve Opana ER

June 9, 2017

Clinical Psychiatry News

FDA approves generic Strattera for pediatric, adult ADHD patients

May 31, 2017

Clinical Psychiatry News

Alzheimer’s mortality in U.S. grew from 1999 to 2014

May 25, 2017

Clinical Psychiatry News

FDA approves new treatment for episodic cluster headaches in adults

April 19, 2017

Clinical Psychiatry News

FDA approves Ingrezza for tardive dyskinesia in adults

April 12, 2017

Clinical Psychiatry News

FDA approves deutetrabenazine for Huntington’s-associated chorea

April 4, 2017

Clinical Psychiatry News

FDA approves safinamide to treat Parkinson’s disease

March 22, 2017

Clinical Psychiatry News

Brodalumab approved for psoriasis with REMS required

February 16, 2017

Depression

Clinical Psychiatry News

Latuda receives FDA approval for adolescent schizophrenia treatment

January 31, 2017